Bo Sun

Title: Innovations of Bo Sun in Nanoparticle Formulation

Introduction

Bo Sun is an accomplished inventor based in West Lafayette, IN (US). He has made significant contributions to the field of drug delivery systems, particularly through his innovative work on carrier-free nanoparticles. His research focuses on enhancing the efficacy of anticancer drug delivery methods.

Latest Patents

Bo Sun holds a patent for a formulation of carrier-free nanoparticles designed for anticancer drug delivery. This formulation demonstrates good circulation stability and is made from nanocrystals crystallized in a medium containing Pluronic F-127, which are then coated with albumin. The resulting product, known as Cim-F-Alb, exhibits the smallest size and the most native albumin compared to other formulations. It shows favorable cell interaction profiles and better stability than the commercial albumin-based formulation, Abraxane, while maintaining comparable cytotoxicity to both Abraxane and solvent-dissolved paclitaxel (PTX).

Career Highlights

Bo Sun is affiliated with the Purdue Research Foundation, where he continues to advance his research in nanoparticle technology. His work has the potential to significantly impact the field of cancer treatment by improving drug delivery systems.

Collaborations

He has collaborated with notable colleagues, including Yoon Yeo and Joonyoung Park, to further enhance the research and development of nanoparticle formulations.

Conclusion

Bo Sun's innovative work in the development of carrier-free nanoparticles represents a significant advancement in anticancer drug delivery systems. His contributions are paving the way for more effective treatment options in the fight against cancer.